Barcelona 2015 Programme Registration Glaucoma Day 2015 Exhibition Virtual Exhibition Satellite Meetings Hotel Booking Star Alliance
ISTANBUL escrs









Take a look inside the London 2014 Congress

video-icon

Then register to join us
in Barcelona!





Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Functional results of trifocal pseudophakic IOL implantation

Poster Details

First Author: E.Malyutina RUSSIA

Co Author(s):    B. Malyugin   T. Morozova                 

Abstract Details

Purpose:

To assess functional outcomes of trifocal AT LISA TRI 839MP implantation

Setting:

S.Fyodorov Eye Microsurgery Complex Federal Institution, Moscow, Russia.

Methods:

16 patients (22 eyes) 10-men, 6-women with the mean age of 66,0±5,81 years (from 52 to 72) underwent the phacoemulsification with IOL implantation in one (10) or both (6) eyes. Patients having ocular comorbidity and corneal astigmatism exceeding 1.0 D were excluded from the study. All procedures were conducted through 2,0 mm incision. IOLs diopter range varied from +17,5 to +24,5. UCVA and BCVA were evaluated uncorrected at a distance of 4,0m, 0,66m and 0,33 m. We also assessed the mean spherical equivalent (SE) and patients subjective satisfaction with of the help of a questionnaire.

Results:

The baseline visual acuity ranged from pr. l. certae to 0,7 with correction. First day after the surgery the UCVA for distance, intermediate and near was 0,80±0,12; 0,6±0,12; 0,82±0,14 respectfully, while BCVA was 0,86±0,13; 0,75±0,11; 0,85±0,11. One week later the UCVA increased to 0,87±0,09; 0,67±0,10; 0,87±0,12 for distance, intermediate and near, while the BCVA reached 0,93±0,08; 0,72±0,1; 0,88±0,11. There were no significant changes thereafter. Postoperative mean SE was -0,28±0,47 (range from +0.25Д to -0.75Д). None of the patient used spectacles for near, intermediate and distance.

Conclusions:

Trifocal IOL AT LISA TRI 839MP provides high visual acuity for near, intermediate and far. Postoperative period was marked by high level of subjective patient’s satisfaction (questionnaire scores).

Financial Disclosure:

NONE

Back to Poster listing